Biotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate Increases

Five Star Equities Provides Stock Research on Cytokinetics and Galectin Therapeutics

Continue Reading

Guidelines of New “Stress Tests” Announced – Focused on the Handling of Major Recessions in China and Europe

Five Star Equities Provides Stock Research on U.S. Bancorp and Hudson City Bancorp

Continue Reading

Biotech Industry Experiencing a Higher Amount of FDA New Drug Approvals in 2012

Five Star Equities Provides Stock Research on Discovery Laboratories and Cardium Therapeutics

Continue Reading

Improving Trend in FDA First Cycle Review Approvals a Major Factor for Biotech Industry-s Success in 2012

Five Star Equities Provides Stock Research on Ariad Pharmaceuticals and AVEO Pharmaceuticals

Continue Reading

FDA on Pace to Approve More New Drugs in 2012 Than the 30 Approved in 2011

Five Star Equities Provides Stock Research on CytRx and ZIOPHARM Oncology

Continue Reading

Improving Trend in FDA First Cycle Review Approvals a Major Factor for Biotech Industry-s Success in 2012

Five Star Equities Provides Stock Research on Amgen and Regeneron Pharmaceuticals

Continue Reading

Biotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate Increases

Five Star Equities Provides Stock Research on Orexigen Therapeutics and PDL BioPharma

Continue Reading

Increased Iron Ore Demand From China in the Fourth Quarter to Help Ease Shipping Industry-s Oversupply

Five Star Equities Provides Stock Research on Navios Maritime and Overseas Shipholding Group

Continue Reading

FDA on Pace to Approve More New Drugs in 2012 Than the 30 Approved in 2011

Five Star Equities Provides Stock Research on Astex Pharmaceuticals and Amicus Therapeutics

Continue Reading

Arena Pharmaceuticals and VIVUS Look to Benefit as Aetna Provides Coverage for Anti-Obesity Drugs

Five Star Equities Provides Stock Research on Arena Pharmaceuticals and VIVUS

Continue Reading